Arrhythmogenic right ventricular dysplasia: Difference between revisions

(Text replacement - "==Diagnosis==" to "==Evaluation==")
(Add See Also section)
 
(18 intermediate revisions by 6 users not shown)
Line 1: Line 1:
==Background==
==Background==
*ARVD is a significant contributor to sudden cardiac death in young patients
[[File:Arrhythmogenic right ventricular cardiomyopathy.jpg|thumb|In vitro MRI and corresponding cross section of the heart in ARVD show RV dilatation with anterior and posterior aneurysms (17-year-old asymptomatic male athlete who died suddenly during a soccer game).]]
*More common in males and those of Mediterranean descent
*Second most common cause of sudden cardiac death in young patients <ref>https://litfl.com/arrhythmogenic-right-ventricular-cardiomyopathy-arvc/</ref>
**Up to 20% of sudden cardiac deaths in young people
*Usually occurs in people of Greek or Italian descent
*Male:Female = 3:1
*1:1000-10,000 in the US
*1:1000-10,000 in the US
*Fibro-fatty replacement of myocardium
*Fibro-fatty replacement of right ventricular myocardium
*Two forms:
**Autosomal dominant
***Variable penetrance
**Autosomal recessive
***Naxos disease (Palmoplantar keratoderma) <ref>Protonotarios, N., and Tsatsopoulou, A. (2006). Naxos disease: Cardiocutaneous syndrome due to cell adhesion defect. Orphanet Journal of Rare Diseases, 1(4).</ref>


==Clinical Features==
==Clinical Features==
*Syncope
*[[Palpitations]] (27%)
*Ventricular dysrhythmia/cardiac arrest
*[[Syncope]] (26%)
*[[Ventricular dysrhythmias]]/[[cardiac arrest]] (23%)
**Especially occurring during exercise
*Family history of unexplained syncope or sudden death
*Family history of unexplained syncope or sudden death
*Dysrhythmias refractory to anti-dysrhythmic meds
*[[Dysrhythmias]] refractory to antidysrhythmic meds
*Asymptomatic (40%)
**Usually these patients are identified through genetic testing of an affected or symptomatic family member
*[[CHF|Right ventricular failure]] (6%)
*[[Dilated cardiomyopathy]]
*[[Dyspnea]]
*Atypical [[chest pain]] (6%)


==Differential Diagnosis==
==Differential Diagnosis==
Line 17: Line 33:


==Evaluation==
==Evaluation==
===ECG===
===[[ECG]]===
[[File:ARVD.png|250px]]
[[File:ARVDV1.png|thumb|Epsilon Wave in Lead V1]]
*Epsilon wave, 30-50%
[[File:ARVD.png|thumb|]]
*V1-V3 TWI (especially in patients >14 yrs old), 85%
*Epsilon wave
*V1-V3 QRS widening
**Seen in 30-50% of cases
*Sudden VT episodes with a LBBB morphology
**Most specific finding
**Small positive deflection at the end of the QRS complex
*V1-V3 T wave inversions
**Seen in 85% of cases
**Especially in patients >14 yrs old)
*Localised QRS widening
**110 ms in V1-V3
*Sudden VT episodes with LBBB morphology
*Prolonged S-wave upstroke
**55 ms in V1-3
**Seen in 95% of cases
 
===Imaging===
===Imaging===
Major and minor criteria rely on echo and cardiac MRI
[[File:Arvd MRI.jpg|thumb|MRI in a patient affected by ARVC/D (long axis view of the right ventricle): note the transmural diffuse bright signal in the RV free wall on spin echo T1 (a) due to massive myocardial atrophy with fatty replacement (b).]]
*Echo - hypokinetic and dilated RV, dilation of RVOT
''Major and minor criteria rely on echo and cardiac MRI''
*Cardiac MRI - fibro-fatty change with RV myocardial thinning, RV aneurysms, RV dilatation
*[[Echocardiography]]
**Hypokinetic and dilated right ventricle
**Dilation of RVOT
*Cardiac MRI <ref>https://litfl.com/arrhythmogenic-right-ventricular-cardiomyopathy-arvc/</ref>
**Fibro-fatty infiltration
**Thinning of right ventricular myocardium
**RV aneurysm
**RV dilatation
**Regional wall motion abnormalities
**Global systolic dysfunction
*Histological studies provide post-mortem diagnosis
**May prompt testing in family members


==Management==
==Management==
*Sotalol is the preferred anti-dysrhythmic
*[[Beta blockers]] or [[amiodarone]] to suppress ventricular dysrhythmias
*Manage heart failure in the usual manner
**[[Sotalol]] is preferred
*ICD implantation if high-risk features
*Ablation of conduction pathways
*Treat [[heart failure]] with [[diuretics]], [[ACE inhibitors]]
*Heart transplant


==Disposition==
==Disposition==
*Symptomatic presentation: Admission to cardiology
*Admission under cardiology if symptomatic
*Admission under cardiology if high-risk features<ref>https://litfl.com/arrhythmogenic-right-ventricular-cardiomyopathy-arvc/</ref>:
**Syncope due to cardiac arrest
**Recurrent dysrhythmias not suppressed by drug therapy
**Cardiac arrest in first-degree relative
*Incidental finding: Cardiology follow-up for further risk assessment and possible ICD placement or ablation
*Incidental finding: Cardiology follow-up for further risk assessment and possible ICD placement or ablation
==See Also==
*[[Sudden cardiac death]]
*[[Ventricular tachycardia]]
*[[Cardiomyopathy]]


==References==
==References==

Latest revision as of 09:25, 22 March 2026

Background

In vitro MRI and corresponding cross section of the heart in ARVD show RV dilatation with anterior and posterior aneurysms (17-year-old asymptomatic male athlete who died suddenly during a soccer game).
  • Second most common cause of sudden cardiac death in young patients [1]
    • Up to 20% of sudden cardiac deaths in young people
  • Usually occurs in people of Greek or Italian descent
  • Male:Female = 3:1
  • 1:1000-10,000 in the US
  • Fibro-fatty replacement of right ventricular myocardium
  • Two forms:
    • Autosomal dominant
      • Variable penetrance
    • Autosomal recessive
      • Naxos disease (Palmoplantar keratoderma) [2]

Clinical Features

Differential Diagnosis

Cardiomyopathy

Syncope Causes

T Wave Inversions

Evaluation

ECG

Epsilon Wave in Lead V1
ARVD.png
  • Epsilon wave
    • Seen in 30-50% of cases
    • Most specific finding
    • Small positive deflection at the end of the QRS complex
  • V1-V3 T wave inversions
    • Seen in 85% of cases
    • Especially in patients >14 yrs old)
  • Localised QRS widening
    • 110 ms in V1-V3
  • Sudden VT episodes with LBBB morphology
  • Prolonged S-wave upstroke
    • 55 ms in V1-3
    • Seen in 95% of cases

Imaging

MRI in a patient affected by ARVC/D (long axis view of the right ventricle): note the transmural diffuse bright signal in the RV free wall on spin echo T1 (a) due to massive myocardial atrophy with fatty replacement (b).

Major and minor criteria rely on echo and cardiac MRI

  • Echocardiography
    • Hypokinetic and dilated right ventricle
    • Dilation of RVOT
  • Cardiac MRI [3]
    • Fibro-fatty infiltration
    • Thinning of right ventricular myocardium
    • RV aneurysm
    • RV dilatation
    • Regional wall motion abnormalities
    • Global systolic dysfunction
  • Histological studies provide post-mortem diagnosis
    • May prompt testing in family members

Management

Disposition

  • Admission under cardiology if symptomatic
  • Admission under cardiology if high-risk features[4]:
    • Syncope due to cardiac arrest
    • Recurrent dysrhythmias not suppressed by drug therapy
    • Cardiac arrest in first-degree relative
  • Incidental finding: Cardiology follow-up for further risk assessment and possible ICD placement or ablation

See Also

References

  1. https://litfl.com/arrhythmogenic-right-ventricular-cardiomyopathy-arvc/
  2. Protonotarios, N., and Tsatsopoulou, A. (2006). Naxos disease: Cardiocutaneous syndrome due to cell adhesion defect. Orphanet Journal of Rare Diseases, 1(4).
  3. https://litfl.com/arrhythmogenic-right-ventricular-cardiomyopathy-arvc/
  4. https://litfl.com/arrhythmogenic-right-ventricular-cardiomyopathy-arvc/
  • Anderson EL. Arrhythmogenic right ventricular dysplasia. Am Fam Physician. 2006 Apr 15;73(8):1391-8.
  • Perez Diez D, Brugada J. Diagnosis and Management of Arrhythmogenic Right Ventricular Dysplasia. E-Journal of the ESC Council for Cardiology Practice, European Society of Cardiology 2008.